Those previously classified as morphologic grade 3 astrocytomas would have been treated with radiotherapy alone followed by chemotherapy, while those previously characterised as IDH-mutant glioblastomas would have been treated with concurrent temozolomide-radiotherapy followed by sequential temozolomide. The gene discussed is IDH2; the disease is glioblastoma.